
Uppsala Reports editor
@UMCGlobalSafety
WHO programme / 15 April 2020
Photo: iStock
The WHO Programme for International Drug Monitoring continues to grow. Since we last reported on programme membership (Issue 81, October 2019), three countries have become full members: Luxembourg (January 2020), Saint Vincent and the Grenadines (March), and Nicaragua (April). In addition, Belize and Dominican Republic joined as associate members (January and March, respectively).
The programme now stands at 139 full and 32 associate members.
Read more:
Since its introduction 20 years ago, UMC’s adverse event reporting system has become the world’s most widely used safety surveillance toolkit for medicines and vaccines.
WHO programme / 25 November 2024
Since 2021 PAHO has assisted 12 countries in importing more than 270,000 historic and new cases to the global database.
WHO programme / 27 March 2025
WHO and UMC introduce new VigiBase access conditions, enhancing data sharing clarity and stakeholder confidence in global pharmacovigilance.
WHO programme / 20 March 2025